Patient Satisfaction Client Satisfaction Questionnaire (CSQ‐8) · patients with people with severe mental illnesses
1 finding from 1 review
Quality of Life Manchester Short Assessment (MANSA) · patients with people with severe mental illnesses
1 finding from 1 review
Burden on family Numbers of families stating that overall burden is great · patients with people with severe mental illnesses
CRISIS INTERVENTION may leads to lower burden on family Numbers of families stating that overall burden is… compared with STANDARD CARE (low certainty).
1 finding from 1 review
Hospital use Repeat admissions excluding index admission · patients with people with severe mental illnesses
CRISIS INTERVENTION showed no clear difference in hospital use Repeat admissions excluding index admission compared with STANDARD CARE (high certainty).
1 finding from 1 review
Mental state: important change in mental state · seriously mentally ill people in hospital
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Behaviour: important change in behaviour · seriously mentally ill people in hospital
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Aggression · seriously mentally ill people in hospital
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dosage: important difference in dose used · seriously mentally ill people in hospital
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: important adverse events · seriously mentally ill people in hospital
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Satisfaction with care: important change in satisfaction with care · seriously mentally ill people in hospital
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost: important change in cost · seriously mentally ill people in hospital
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global state: Change over time ‐ no better or deterioration ‐ short term clinically defined · patients with schizophrenia
It is very uncertain whether PERPHENAZINE changes global state: Change over time ‐ no better or deterioration ‐ short… compared with PLACEBO (very low certainty).
1 finding from 1 review
Death ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events: extrapyramidal adverse effects ‐ dystonia ‐ short term · patients with schizophrenia
It is very uncertain whether PERPHENAZINE changes adverse events: extrapyramidal adverse effects dystonia ‐ short term compared with ANY ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
Other adverse events: any serious adverse event ‐ short and long term · patients with schizophrenia
It is very uncertain whether PERPHENAZINE changes other adverse events: any serious adverse event ‐ short and long term compared with ANY ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
Economic outcome ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Service use and hospitalisation: admission ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Relapse · patients with schizophrenia
It is very uncertain whether PERPHENAZINE changes mental state: Relapse ‐ short term clinical diagnosis compared with PLACEBO (very low certainty).
1 finding from 1 review
Adverse events: death ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events: extrapyramidal adverse effects ‐ dystonia ‐ short term · patients with schizophrenia
It is very uncertain whether PERPHENAZINE changes adverse events: extrapyramidal adverse effects ‐ dystonia ‐ short term compared with PLACEBO (very low certainty).
1 finding from 1 review